Pandey, Garima http://orcid.org/0000-0003-0864-4137
Kuykendall, Andrew T.
Reuther, Gary W. http://orcid.org/0000-0002-2317-931X
Article History
Received: 2 November 2021
Revised: 4 January 2022
Accepted: 6 January 2022
First Online: 26 January 2022
Competing interests
: GWR has received research funding from Incyte Corporation and Revolution Medicines, Inc. ATK has served on advisory boards and received honoraria from Celgene/BMS, Abbvie Inc., Novartis, Pharmaessentia Corp., and CTI Biopharma Corp; and received consulting fees from Incyte Corporation; and received research support from Celgene/BMS, Prelude Therapeutics, and Sierra Oncology. None of these companies contributed to the writing of, the editing of, or the decision to submit this publication. GP has nothing to disclose.